Skip to main navigation Skip to search Skip to main content

AP-013 - A Randomized, Sham-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of an Intra-Articular Injection of Ampion in Adults with Pain due to Severe Osteoarthritis of the Knee

Project: Research

Project Details

StatusFinished
Effective start/end date01/18/1901/18/23

Funding

  • Ampio Pharmaceuticals Incorporated: $119,131.70